ZIMMER BIOMET HOLDINGS, INC. Quarterly Costs and Expenses in USD from Q3 2015 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total costs of sales and operating expenses for the period.
Summary: Zimmer Biomet Holdings, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2015 to Q3 2024.
Zimmer Biomet Holdings, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $1.54B, a 3.88% increase year-over-year.
Zimmer Biomet Holdings, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $6.34B, a 0.62% decline year-over-year.
Zimmer Biomet Holdings, Inc. annual Costs and Expenses for 2023 was $6.12B, a 2.04% decline from 2022.
Zimmer Biomet Holdings, Inc. annual Costs and Expenses for 2022 was $6.24B, a 4.64% increase from 2021.
Zimmer Biomet Holdings, Inc. annual Costs and Expenses for 2021 was $5.97B, a 1.28% decline from 2020.

Costs and Expenses, Trailing 12 Months (USD)

Costs and Expenses, Quarterly (USD)

Costs and Expenses, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$6.34B	$1.54B	+$57.7M	+3.88%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-10-30
Q2 2024	$6.29B	$1.59B	+$50.9M	+3.31%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$6.24B	$1.62B	+$120M	+7.95%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$6.12B	$1.59B	-$268M	-14.4%	Oct 1, 2023	Dec 31, 2023	8-K	2024-08-07
Q3 2023	$6.38B	$1.49B	+$62.5M	+4.39%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-10-30
Q2 2023	$6.32B	$1.54B	+$39M	+2.6%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	$6.28B	$1.5B	+$38.9M	+2.66%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-02
Q4 2022	$6.24B	$1.85B	+$210M	+12.8%	Oct 1, 2022	Dec 31, 2022	8-K	2024-08-07
Q3 2022	$6.03B	$1.42B	-$17.9M	-1.24%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	$6.05B	$1.5B	-$37.6M	-2.44%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-01
Q1 2022	$6.09B	$1.46B	+$122M	+9.09%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-02
Q4 2021	$5.97B	$1.64B	+$867M	+112%	Oct 1, 2021	Dec 31, 2021	8-K	2024-08-07
Q3 2021	$5.1B	$1.44B	-$188M	-11.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-02
Q2 2021	$5.29B	$1.54B	+$141M	+10.1%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-02
Q1 2021	$5.15B	$1.34B	-$897M	-40.1%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	$6.04B	$777M	-$16.1M	-2.03%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-24
Q3 2020	$6.06B	$1.63B	-$16.5M	-1%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$6.08B	$1.4B	-$386M	-21.6%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-03
Q1 2020	$6.46B	$2.24B	+$615M	+37.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-04
Q4 2019	$5.85B	$793M	-$2.07B	-72.3%	Oct 1, 2019	Dec 31, 2019	8-K	2022-06-22
Q3 2019	$7.92B	$1.65B	+$33.2M	+2.06%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-06
Q2 2019	$7.88B	$1.78B	+$72.3M	+4.22%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-05
Q1 2019	$7.81B	$1.63B	-$87.3M	-5.1%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q4 2018	$7.9B	$2.86B	+$753M	+35.7%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-22
Q3 2018	$7.15B	$1.61B	+$11.5M	+0.72%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-05
Q2 2018	$7.13B	$1.71B	+$42.2M	+2.53%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-05
Q1 2018	$7.09B	$1.71B	+$88.3M	+5.44%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-06
Q4 2017	$7B	$2.11B	+$289M	+15.9%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-21
Q3 2017	$6.71B	$1.6B	-$35.4M	-2.16%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-01
Q2 2017	$6.75B	$1.67B	-$63M	-3.64%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-06
Q1 2017	$6.81B	$1.62B	-$34.2M	-2.06%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-08
Q4 2016	$6.85B	$1.82B			Oct 1, 2016	Dec 31, 2016	10-K	2019-02-26
Q3 2016		$1.64B	-$8.9M	-0.54%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-06
Q2 2016		$1.73B			Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-08
Q1 2016		$1.66B			Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-09
Q3 2015		$1.65B			Jun 25, 2015	Sep 30, 2015	10-Q	2016-11-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.